| 2025 | 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 42,4 M € | +0.3% | 42,2 M € | +7.7% | 39,2 M € | +6.5% | 36,8 M € | +20.9% | 30,5 M € | +26.7% | 24,0 M € | +3.1% | 23,3 M € | +4.2% | 22,4 M € | +1.5% | 22,0 M € | +8.0% | 20,4 M € | +1.0% | 20,2 M € | -2.3% | 20,7 M € | +8.8% | 19,0 M € | +11.7% | 17,0 M € | +9.9% | 15,5 M € | -0.0% | 15,5 M € | +3.6% | 14,9 M € | +5.2% | 14,2 M € | |
| EBITDA | 13,3 M € | -5.6% | 14,1 M € | +8.8% | 12,9 M € | +2.3% | 12,6 M € | +29.9% | 9,7 M € | +37.0% | 7,1 M € | +3.3% | 6,9 M € | +10.5% | 6,2 M € | +6.8% | 5,8 M € | +7.9% | 5,4 M € | +7.3% | 5,0 M € | +19.1% | 4,2 M € | +56.9% | 2,7 M € | -3.1% | 2,8 M € | +13.9% | 2,4 M € | -5.4% | 2,6 M € | -13.7% | 3,0 M € | -2.1% | 3,1 M € | |
| Operating profit | 12,0 M € | -7.6% | 13,0 M € | +3.0% | 12,7 M € | +17.4% | 10,8 M € | +23.2% | 8,8 M € | +54.1% | 5,7 M € | -2.7% | 5,8 M € | +14.5% | 5,1 M € | +6.5% | 4,8 M € | +11.2% | 4,3 M € | +6.3% | 4,0 M € | +25.8% | 3,2 M € | +63.4% | 2,0 M € | -8.8% | 2,2 M € | +47.5% | 1,5 M € | +21.3% | 1,2 M € | -21.9% | 1,5 M € | -4.6% | 1,6 M € | |
| Profit/loss | 9,2 M € | -7.7% | 10,0 M € | +2.3% | 9,7 M € | +14.9% | 8,5 M € | +25.2% | 6,8 M € | +62.4% | 4,2 M € | +3.8% | 4,0 M € | +18.1% | 3,4 M € | +0.8% | 3,4 M € | +10.7% | 3,0 M € | +7.3% | 2,8 M € | +22.8% | 2,3 M € | +28.1% | 1,8 M € | +14.9% | 1,6 M € | +40.5% | 1,1 M € | +14.2% | 978,4 k € | -22.9% | 1,3 M € | -3.1% | 1,3 M € | |
| Equity | 15,1 M € | +26.8% | 11,9 M € | +40.5% | 8,5 M € | -60.4% | 21,4 M € | +31.8% | 16,2 M € | +45.0% | 11,2 M € | +10.9% | 10,1 M € | +11.0% | 9,1 M € | +7.4% | 8,5 M € | +4.0% | 8,1 M € | +2.7% | 7,9 M € | +7.3% | 7,4 M € | +7.4% | 6,9 M € | +3.7% | 6,6 M € | +7.4% | 6,2 M € | +22.1% | 5,1 M € | +0.1% | 5,1 M € | +0.2% | 5,0 M € | |
| Total assets | 28,4 M € | +0.2% | 28,3 M € | +12.5% | 25,2 M € | -1.8% | 25,6 M € | +27.7% | 20,1 M € | +45.6% | 13,8 M € | +0.8% | 13,7 M € | +6.7% | 12,8 M € | +15.8% | 11,1 M € | +2.5% | 10,8 M € | +5.0% | 10,3 M € | +5.3% | 9,8 M € | -2.8% | 10,1 M € | +16.6% | 8,6 M € | +13.0% | 7,6 M € | +2.7% | 7,4 M € | -5.6% | 7,9 M € | +3.9% | 7,6 M € | |
| Cash | 11,1 M € | +4.4% | 10,6 M € | +27.3% | 8,3 M € | -11.1% | 9,4 M € | +32.1% | 7,1 M € | +17.8% | 6,0 M € | -0.3% | 6,1 M € | +24.2% | 4,9 M € | +59.1% | 3,1 M € | -11.7% | 3,5 M € | -28.8% | 4,9 M € | +43.4% | 3,4 M € | +96.7% | 1,7 M € | -31.3% | 2,5 M € | +46.9% | 1,7 M € | -33.0% | 2,6 M € | +73.2% | 1,5 M € | +67.3% | 881,9 k € | |
| Debts | 12,5 M € | -20.4% | 15,7 M € | -0.7% | 15,8 M € | +364.2% | 3,4 M € | +1.4% | 3,4 M € | +62.8% | 2,1 M € | -13.2% | 2,4 M € | +2.1% | 2,3 M € | +28.5% | 1,8 M € | -5.0% | 1,9 M € | +19.9% | 1,6 M € | -4.1% | 1,7 M € | -32.7% | 2,5 M € | +79.3% | 1,4 M € | +53.0% | 897,8 k € | -53.0% | 1,9 M € | -21.8% | 2,4 M € | +9.8% | 2,2 M € | |
| Staff | 130 | 121,8 | 118,2 | 113,5 | 107 | 98,8 | 91,7 | 86,2 | 82,9 | 83,7 | 82,1 | 80,5 | 78,4 | 68,1 | 70,9 | 71,9 | 74,6 | 68 | ||||||||||||||||||
Public limited company · Boechout · incorporated on 15/01/1991 · 130,0 ETP
Public limited company profitable and well capitalised.
Solid counterparty for a standard engagement.
REYNDERS PHARMACEUTICAL LABELS is a Public limited company incorporated in 1991. Its main activity is: Manufacture of articles of paper and paperboard. Its registered office is in Boechout. It employs on average 130,0 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette